Word: succession
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Despite the fact that CCX is entirely voluntary - meaning the U.S. companies that participate in it aren't being forced to make emissions cuts - the market has been a success. Today, he notes, CCX has more than 400 corporate members, who last year traded 23 million tons worth of carbon emissions - up from 10.3 million in 2006. Over in London, where Sandor opened up a European Climate Exchange - and where companies labor under Kyoto-mandatory carbon caps - trading has been strong, and the company itself is worth over $1 billion. "Carbon cap and trade is not a thing of tomorrow...
...Behind these sentiments lurks the endemic self-loathing that subtly defines many Harvard students’ view of their own success in the college admissions cockfight. We are selfish when it comes to rooming and selfless on the subject of transfer admissions because we’re embarrassed to be among higher education’s Elect, the less-than-ten percent of the applicant pool that did the impossible and got into Harvard...
...when having one’s own single is fast becoming an unattainable dream, every new transfer is a reason why Winthrop seniors will be living in common rooms and Dunster residents will continue to live in closets. And though making a show of our insecurities about our own success is certainly endearing, current undergraduates might forgive themselves a little bit of selfishness where personal space is concerned, at least...
...between white and minority students persists. RE-EXAMINING THE GAPCRLS senior Emma L. Shreefter said that she thinks the district takes a “skewed” approach to student achievement. “I think that, ever since I was a freshman, the achievement and push for success is only for certain students—usually by race, gender, and socioeconomic status, which has really bothered me,” said Shreefter, who is also a student representative to the school committee. “It’s about showing the student they’re just...
...hospital wrote that, based on the success in mice, associate professor Richard M. Stone is launching phase I clinical trials in patients at the Dana-Farber Cancer Institute to determine whether humans can safely use the drug...